NewsDesk  @infectiousdiseasenews Ocugen, Inc. and Bharat Biotech announced yesterday results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose...

By NewsDesk  @infectiousdiseasenews GSK, PATH, and Bharat Biotech (BBIL) Wednesday announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes the...

At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting...